Dr. Agarwal's Health Care FY26 PAT Soars 52.4% to ₹168 Cr

Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting strong growth.
FY26 consolidated PAT grew 52.4% YoY to ₹168 Cr on revenue of ₹2,125 Cr, with EBITDA at ₹614 Cr up 22.2%.
Board reallocated ₹14.88 Cr unspent IPO proceeds from 'Issue Expenses' to 'General Corporate Purposes'.
Company expanded network to 288 facilities across 10 countries, adding 57 new centers in FY26.